- Home
- NBY vs ONTO Comparison
NBY vs ONTO Comparison
Compare NBY & ONTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- ONTO
- Stock Information
- Founded
- NBY 2000
- ONTO 1940
- Country
- NBY United States
- ONTO United States
- Employees
- NBY N/A
- ONTO N/A
- Industry
- NBY
- ONTO Industrial Machinery/Components
- Sector
- NBY
- ONTO Industrials
- Exchange
- NBY Nasdaq
- ONTO Nasdaq
- Market Cap
- NBY 15.7M
- ONTO 4.9B
- IPO Year
- NBY 2007
- ONTO N/A
- Fundamental
- Price
- NBY $1.75
- ONTO $115.98
- Analyst Decision
- NBY Strong Buy
- ONTO Strong Buy
- Analyst Count
- NBY 1
- ONTO 7
- Target Price
- NBY $0.85
- ONTO $137.86
- AVG Volume (30 Days)
- NBY 21.1M
- ONTO 1.1M
- Earning Date
- NBY 11-06-2025
- ONTO 10-30-2025
- Dividend Yield
- NBY N/A
- ONTO N/A
- EPS Growth
- NBY N/A
- ONTO 20.58
- EPS
- NBY 0.41
- ONTO 4.04
- Revenue
- NBY $9,781,000.00
- ONTO $1,036,353,000.00
- Revenue This Year
- NBY $23.91
- ONTO $3.11
- Revenue Next Year
- NBY $32.05
- ONTO $9.04
- P/E Ratio
- NBY $4.97
- ONTO $28.79
- Revenue Growth
- NBY 113.47
- ONTO 15.51
- 52 Week Low
- NBY $0.46
- ONTO $85.88
- 52 Week High
- NBY $4.44
- ONTO $228.42
- Technical
- Relative Strength Index (RSI)
- NBY 48.05
- ONTO 63.24
- Support Level
- NBY $2.28
- ONTO $102.91
- Resistance Level
- NBY $3.30
- ONTO $122.21
- Average True Range (ATR)
- NBY 0.64
- ONTO 3.93
- MACD
- NBY -0.10
- ONTO 1.22
- Stochastic Oscillator
- NBY 10.03
- ONTO 70.60
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About ONTO Onto Innovation Inc.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.